McKesson Corp.

North Texas’ McKesson Launches InspiroGene to Support Commercialization of Cell and Gene Therapies

by | Oct 1, 2024
McKesson said that with a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape—ensuring that "patients can access the life-changing treatments they need."
MORE
North Texas’ McKesson To Acquire Majority Stake in Florida Cancer Healthcare Network for $2.49 Billion
by | Aug 26, 2024
Florida-based Core Ventures was established by the Florida Cancer Specialists & Research Institute, a physician-owned community oncology practice. With the multi-billion-dollar acquisition, CORE Ventures will join McKesson's US Oncology Network to advance "affordable cancer care and better patient outcomes."
MORE
McKesson Unveils New Private Brand of Over-the-Counter Pharmacy Products
by | Jun 22, 2023
Foster & Thrive unifies McKesson's private brand portfolio—consolidating Health Mart and Sunmark branded OTC products— and aims to offer greater availability through increased production and efficiencies to help meet evolving patient needs and growing demand.
MORE
Meet the Finalists: The Innovation Awards 2022, Presented by Dallas Innovates and D CEO
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE